CompoAtlas

Immunexx

Natural health product licensed in Canada

Licence holder
Viatrexx (8046255 Canada Inc)
NPN or DIN-HM
80057618
Status
Active licence
Licence date
23 January 2015
Revision date
Not provided
Form
Vaporisateur
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Sus scrofa

Source : Glande surrénale

6 XNot calculated
Sus scrofa

Source : Glande surrénale

200 KNot calculated
Sus scrofa

Source : Moelle osseuse

8 XNot calculated
Sus scrofa

Source : Moelle osseuse

30 KNot calculated
Sus scrofa

Source : Erythrocytes

8 XNot calculated
Sus scrofa

Source : Globules rouges

8 XNot calculated
Sus scrofa

Source : Erythrocytes

200 KNot calculated
Sus scrofa

Source : Globules rouges

200 KNot calculated
Sus scrofa

Source : Glande lymphatique

8 XNot calculated
Sus scrofa

Source : Glande lymphatique

200 KNot calculated
Sus scrofa

Source : Plaques de Peyer

8 XNot calculated
Sus scrofa

Source : Plaques de Peyer

200 KNot calculated
Sus scrofa

Source : Rate

8 XNot calculated
Sus scrofa

Source : Rate

200 KNot calculated
Sus scrofa

Source : Thymus

6 CNot calculated
Sus scrofa

Source : Thymus

200 KNot calculated

Non-medicinal ingredients

Ethanol 20%

PopulationAgeQuantity per servingFrequency
Adultes et enfantsminimum: 13 yearsminimum: 1 Pulvérisateur ; maximum: 5 Pulvérisateurminimum: 1 Tous les jours ; maximum: 3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Organotherapy preparation

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80057618

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line